ArticleDrug, healthcare and patient safety2026

Adverse Events Associated with Tirzepatide: Updated Pharmacovigilance Analysis Using FAERS (2022 Q1-2025 Q1) with an Adapted Time-to-Onset Method.

Saisai GuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.